Image de couverture de livre

A new name for an old problem. Metabolic dysfunction-associated steatotic liver disease - review of literature

Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) was previously known as non-alcoholic fatty liver disease (NAFLD). MASLD is one of the most important and leading causes of liver disease worldwide. This disease is a public health challenge in the 21st century. Aim of th...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Adrian Kruszewski (Auteur), Anna Dąbrowska (Auteur), Paulina Przybysz (Auteur), Maja Kucharska (Auteur), Monika Szyszka (Auteur), Natalia Paduszyńska (Auteur), Karolina Błaszczak (Auteur)
Format:	Livre
Publié:	Nicolaus Copernicus University in Toruń, 2024-07-01T00:00:00Z.
Sujets:	article
Accès en ligne:	Connect to this object online.
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Pathogenesis, diagnosis and current treatment of prolactinoma: a review of the literature
par: Monika Szyszka, et autres
Publié: (2024)

Sport and type 1 diabetes - a great value but also a challenge. Review of the literature and guidelines
par: Karolina Błaszczak, et autres
Publié: (2024)

Optimizing Physical Activity for Glycemic Control in Type 1 Diabetes: Strategies and Risks
par: Paulina Przybysz, et autres
Publié: (2024)

Understanding the Pathophysiology of Atopic Dermatitis - insights into Immune Dysregulation and Skin Barrier Dysfunction
par: Maja Kucharska, et autres
Publié: (2024)

Proton Pump Inhibitors. Investigating Their Role in Small Intestinal Bacterial Overgrowth
par: Adrian Kruszewski, et autres
Publié: (2024)

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
par: Emidio Scarpellini, et autres
Publié: (2024)

Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
par: Jiaxin Chen, et autres
Publié: (2024)

Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions
par: O.E. Abaturov, et autres
Publié: (2024)

Iron, Oxidative Stress, and Metabolic Dysfunction-Associated Steatotic Liver Disease
par: Sophie Gensluckner, et autres
Publié: (2024)

Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
par: Yumin Wang, et autres
Publié: (2024)

Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs
par: Baoqiang Zhu, et autres
Publié: (2023)

Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives
par: Torre E, et autres
Publié: (2024)

Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography
par: Myung Jin Kim, et autres
Publié: (2024)

Correlation Between Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Urinary Incontinence in Adult Women
par: Zhang F, et autres
Publié: (2024)

Self-management in patients with metabolic dysfunction-associated steatotic liver disease: influencing factors and impact on readmission
par: Xiuli Lin, et autres
Publié: (2024)

Melatonin Prevents Alcohol- and Metabolic Dysfunction- Associated Steatotic Liver Disease by Mitigating Gut Dysbiosis, Intestinal Barrier Dysfunction, and Endotoxemia
par: Karli R. LeFort, et autres
Publié: (2023)

Association between life's essential 8 and metabolic dysfunction-associated steatotic liver disease among US adults
par: Zheng Wang, et autres
Publié: (2024)

Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD: Jordan’s Perspective Based on Knowledge and Attitude Determinants
par: Alqudah O, et autres
Publié: (2024)

Myokines and Their Potential Protective Role Against Oxidative Stress in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
par: José Luis Bucarey, et autres
Publié: (2024)

Exploratory Role of Flavonoids on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a South Italian Cohort
par: Caterina Bonfiglio, et autres
Publié: (2024)

Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity
par: Huanyu Wang, et autres
Publié: (2024)

Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study
par: Gabriela Wünsch Lopes, et autres
Publié: (2024)

Association between diet soft drink consumption and metabolic dysfunction-associated steatotic liver disease: findings from the NHANES
par: Yanrui Wu, et autres
Publié: (2023)

Association of niacin intake and metabolic dysfunction-associated steatotic liver disease: findings from National Health and Nutrition Examination Survey
par: Jing Zhou, et autres
Publié: (2024)

PARADOXICAL ASSOCIATION OF LOW LIPOPROTEIN (A) WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE SEVERITY: FINDINGS FROM THE UK BIOBANK
par: Terence B Lee, MD
Publié: (2024)

Occupational stress trajectories and metabolic dysfunction-associated steatotic liver disease among female nurses: a prospective Cohort Study
par: Hanxiao Luo, et autres
Publié: (2024)

Non-linear association between long-term air pollution exposure and risk of metabolic dysfunction-associated steatotic liver disease
par: Wei-Chun Cheng, et autres
Publié: (2024)

Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges
par: Ying Yang, et autres
Publié: (2024)

The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
par: Li N, et autres
Publié: (2024)

Allergic rhinitis - a review of current diagnostic and therapeutic methods
par: Kacper Kwiliński, et autres
Publié: (2024)

Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease
par: Hye Young Jin, et autres
Publié: (2024)

Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study
par: Da-Hye Son, et autres
Publié: (2024)

Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions
par: Xiaoxiao Li, et autres
Publié: (2024)

Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: a systematic review and meta-analysis
par: Asma Jamil, et autres
Publié: (2024)

Glucagon-like Peptide-1 Receptor Agonists-A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)
par: Erika Choi, et autres
Publié: (2024)

High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia
par: Patricia C. Valery, et autres
Publié: (2024)

A Case-Control Study Supports Genetic Contribution of the <i>PON</i> Gene Family in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease
par: Evelien Van Dijck, et autres
Publié: (2024)

A novel fatty acid mimetic with pan-PPAR partial agonist activity inhibits diet-induced obesity and metabolic dysfunction-associated steatotic liver disease
par: Cigdem Sahin, et autres
Publié: (2024)

Low-dose valine attenuates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) in mice by enhancing leptin sensitivity and modulating the gut microbiome
par: Felicianna, et autres
Publié: (2024)

<i>Clinopodium gracile</i> Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Upregulating Peroxisome Proliferator-Activated Receptor α and Inhibiting Mitochondrial Oxidative Damage
par: Mingshi Ren, et autres
Publié: (2024)